Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03218683
Title Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

multiple myeloma

peripheral T-cell lymphoma

non-Hodgkin lymphoma

Richter's syndrome

Therapies

AZD5991

Age Groups:
Covered Countries USA


No variant requirements are available.